Smiths Group PLC

Director's Dealing • Oct 9, 2019

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 3412P

Smiths Group PLC

09 October 2019

9 OCTOBER 2019

NOTIFICATIONS OF TRANSACTIONS OF DIRECTORS / PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

MR ANDREW REYNOLDS SMITH

2

Reason for the notification

a)

Position/status

CHIEF EXECUTIVE

b)

Initial Notification / Amendment

INITIAL NOTIFICATION

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

SMITHS GROUP PLC

b)

LEI

213800MJL6IPZS3ASA11

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument,

type of instrument

Identification code

ORDINARY SHARES OF 37.5P EACH IN SMITHS GROUP PLC ("ORDINARY SHARES")

ISIN GB00B1WY2338

b)

Nature of the transaction  

1.   VESTING OF AN AWARD UNDER THE SMITHS GROUP LONG TERM INCENTIVE PLAN ("LTIP");

2.   VESTING OF THE SECOND TRANCHE OF A PERFORMANCE SHARE AWARD ("PSA"); AND

3.   MARKET SALE OF SHARES TO FINANCE INCOME TAX AND NATIONAL INSURANCE LIABILITIES ARISING ON THE VESTING OF THE AWARDS

c)

Price(s) and volume(s)

	Price(s)	Volume(s)
1.  Vesting of LTIP Award	N/A	125,805
2.  Vesting of PSA Award	N/A	22,492
3.  Sale by Andrew Reynolds Smith	£15.388187	69,875

d)

Aggregated information

- Aggregated volume

- Price

Acquisitions: 148,297

Sales: 69,875 at £15.388187 per share

e)

Date of the transaction

2019-10-08

f)

Place of the transaction

London Stock Exchange (XLON)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DSHCKCDQNBDDFKK